Market revenue in 2023 | USD 26.3 million |
Market revenue in 2030 | USD 44.0 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.79% in 2023. Horizon Databook has segmented the Denmark real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
Real-world evidence (RWE) is obtained from multiple sources and analyzed from Real-World Data (RWD) to generate high-quality, transparent evidence that addresses healthcare needs. This evidence can be used throughout the product life cycle, from disease epidemiology to treatment effectiveness, safety, and economic value.
Furthermore, several companies in the country offer their expertise in RWE; for instance, Evident IQ, a leading next-generation technology and data science company, combines its expertise in data sciences with a global patient platform to generate real-world patient evidence.
The company's approach allows it to leverage the power of RWE to provide valuable insights into health economics. Similarly, the NHTA market access in Denmark has been granted permission to access patient-level data from various Danish registries through Statistics Denmark.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account